Document Detail

Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis.
MedLine Citation:
PMID:  25237044     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Galectin-3 is a biomarker for prognostication and risk stratification of patients with heart failure (HF). It has been suggested that renal function strongly relates to galectin-3 levels. We aimed to describe galectin-3 renal handling in HF.
METHODS AND RESULTS: In Sprague-Dawley rats, we infused galectin-3 and studied distribution and renal clearance. Furthermore, galectin-3 was measured in urine and plasma of healthy controls, HF patients and hemodialysis patients. To mimic the human situation, we measured galectin-3 before and after the artificial kidney. Infusion in rats resulted in a clear increase in plasma and urine galectin-3. Plasma galectin-3 in HF patients (n=101; mean age 64 years; 93% male) was significantly higher compared to control subjects (n=20; mean age 58 years; 75% male) (16.6 ng/mL versus 9.7 ng/mL, P<0.001), while urinary galectin-3 in HF patients was comparable (28.1 ng/mL versus 35.1 ng/mL, P=0.830). The calculated galectin-3 excretion rate was lower in HF patient (2.3 mL/min [1.5 to 3.4] versus 3.9 mL/min [2.3 to 6.4] in control subjects; P=0.005). This corresponded with a significantly lower fractional excretion of galectin-3 in HF patients (2.4% [1.7 to 3.7] versus 3.0% [1.9 to 5.5]; P=0.018). These differences, however, were no longer significant after correction for age, gender, diabetes, and smoking. HF patients who received diuretics (49%) showed significantly higher aldosterone and galectin-3 levels. Hemodialysis patients (n=105; mean age 63 years; 65% male), without urinary galectin-3 excretion, had strongly increased median plasma galectin-3 levels (70.6 ng/mL).
CONCLUSIONS: In this small cross-sectional study, we report that urine levels of galectin-3 are not increased in HF patients, despite substantially increased plasma galectin-3 levels. The impaired renal handling of galectin-3 in patients with HF may explain the described relation between renal function and galectin-3 and may account for the elevated plasma galectin-3 in HF.
Wouter C Meijers; A Rogier van der Velde; Willem P Ruifrok; Nicolas F Schroten; Martin M Dokter; Kevin Damman; Solmaz Assa; Casper F Franssen; Ron T Gansevoort; Wiek H van Gilst; Herman H Silljé; Rudolf A de Boer
Related Documents :
11971054 - Immunoadsorption inferior to plasma exchange in a patient with chronic inflammatory dem...
2115344 - Ejaculate-hormonal traits in the leopard cat (felis bengalensis) and sperm function as ...
17107514 - Evidence for effects of testis and epididymis expressed genes on sperm quality and boar...
6332104 - Origin of a motility inhibitor within the male reproductive tract.
3207554 - Passage of chloroquine into semen.
6587754 - The influence of calcium antagonists on plasma digoxin concentration.
Publication Detail:
Type:  Journal Article     Date:  2014-09-18
Journal Detail:
Title:  Journal of the American Heart Association     Volume:  3     ISSN:  2047-9980     ISO Abbreviation:  J Am Heart Assoc     Publication Date:  2014  
Date Detail:
Created Date:  2014-09-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101580524     Medline TA:  J Am Heart Assoc     Country:  England    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Copyright Information:
© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mitochondrial Aldehyde Dehydrogenase 2 Plays Protective Roles in Heart Failure After Myocardial Infa...
Next Document:  The early stage of the atrial electroanatomic remodeling as substrates for atrial fibrillation in hy...